Bepirovirsen: Clinical Trials

5 trials of Bepirovirsen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Phase 21Terminated 1

Follow Bepirovirsen: new trials by email Literature Review of Bepirovirsen trials Research Report on Bepirovirsen

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Compare Blood Levels of Bepirovirsen and Safety Using Different Methods of Injecting in Healthy Adult Participants
Bepirovirsen - Hepatitis B
Phase 1Not yet recruitingGlaxoSmithKline982026-11-032026-10-29
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
Bepirovirsen - Hepatitis B
Phase 1Active not recruitingGlaxoSmithKline322025-09-262026-05-22
Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
Bepirovirsen, Placebo - Hepatitis B
Phase 1CompletedGlaxoSmithKline462024-07-182026-07-10
A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants
Bepirovirsen - Hepatitis B
Phase 1CompletedGlaxoSmithKline1602023-10-042025-07-18
Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection
GSK3965193, Placebo to match GSK3965193, Bepirovirsen - Hepatitis B
Phase 1 / Phase 2TerminatedGlaxoSmithKline742022-04-142026-10-14

Conditions studied

Hepatitis B (5)  ·  Liver Diseases (2)  ·  Communicable Diseases (1)  ·  Hepatitis (1)  ·  Hepatitis B, Chronic (1)  ·  Kidney Diseases (1)  ·  Renal Insufficiency (1)  ·  Virus Diseases (1)

Sponsors

GlaxoSmithKline (5)

Countries

United States (3)  ·  Canada (1)  ·  France (1)  ·  Italy (1)  ·  South Korea (1)  ·  Thailand (1)  ·  United Kingdom (1)

Results publications

PMID 42550463, PMID 41085094

NIH funding

2023 (1)